Phreesia (NYSE:PHR) General Counsel Sells $18,116.28 in Stock

by · The Markets Daily

Phreesia, Inc. (NYSE:PHR – Get Free Report) General Counsel Allison Hoffman sold 1,106 shares of the stock in a transaction on Thursday, January 15th. The stock was sold at an average price of $16.38, for a total value of $18,116.28. Following the sale, the general counsel owned 173,656 shares in the company, valued at $2,844,485.28. The trade was a 0.63% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Phreesia Price Performance

Shares of Phreesia stock traded down $0.63 during trading on Tuesday, reaching $15.76. The company’s stock had a trading volume of 888,246 shares, compared to its average volume of 1,011,187. The stock has a 50-day moving average price of $18.24 and a two-hundred day moving average price of $23.18. The stock has a market capitalization of $950.23 million, a P/E ratio of -157.59 and a beta of 0.61. The company has a current ratio of 2.44, a quick ratio of 2.44 and a debt-to-equity ratio of 0.01. Phreesia, Inc. has a one year low of $15.41 and a one year high of $32.76.

Phreesia (NYSE:PHR – Get Free Report) last posted its quarterly earnings data on Monday, December 8th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.11. Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. The firm had revenue of $120.33 million during the quarter, compared to analysts’ expectations of $119.98 million. During the same quarter last year, the company posted ($0.25) EPS. The company’s quarterly revenue was up 12.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Institutional Trading of Phreesia

A number of hedge funds have recently modified their holdings of PHR. Loomis Sayles & Co. L P bought a new position in Phreesia during the 2nd quarter worth approximately $34,162,000. Millennium Management LLC raised its holdings in Phreesia by 730.7% in the third quarter. Millennium Management LLC now owns 1,064,132 shares of the company’s stock worth $25,028,000 after purchasing an additional 936,033 shares during the period. Greenhouse Funds LLLP boosted its position in shares of Phreesia by 16.8% during the third quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company’s stock worth $91,317,000 after purchasing an additional 557,265 shares in the last quarter. Bessemer Group Inc. grew its holdings in shares of Phreesia by 1,065.9% in the 3rd quarter. Bessemer Group Inc. now owns 554,513 shares of the company’s stock valued at $13,043,000 after buying an additional 506,954 shares during the period. Finally, Capricorn Fund Managers Ltd bought a new stake in shares of Phreesia in the 3rd quarter valued at $11,395,000. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have commented on PHR. Barclays decreased their price objective on Phreesia from $26.00 to $24.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 16th. Citigroup decreased their price target on Phreesia from $29.00 to $25.00 and set a “buy” rating on the stock in a report on Friday, January 9th. Robert W. Baird dropped their price objective on Phreesia from $31.00 to $25.00 and set an “outperform” rating for the company in a report on Wednesday, December 10th. Wells Fargo & Company assumed coverage on shares of Phreesia in a research note on Thursday, January 8th. They issued an “overweight” rating and a $30.00 target price on the stock. Finally, DA Davidson lifted their price target on shares of Phreesia from $33.00 to $35.00 and gave the stock a “buy” rating in a research report on Tuesday, December 2nd. Seventeen investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $30.06.

Read Our Latest Report on PHR

Phreesia Company Profile

(Get Free Report)

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.

Read More